Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,379 public trials 1,304 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

NCT02973685

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The First People's Hospital of Foshan Foshan, Guangdong, China

Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China

Guangzhou Twelfth People's Hospital Guangzhou, Guangdong, China

View Trial Details

Completed

HAIC Plus Lenvatinib and Toripalimab for Advanced HCC

NCT04044313

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD

NCT05897606

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Hawal Fateh Kurdistan, Kalar, Iraq

View Trial Details

Completed

Extreme Exercise and Energy Expenditure (4E) Study

NCT05895916

Conditions: Behavior, Body Weight, Cardiovascular Diseases, +20 more
Locations: Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval Québec, Canada

View Trial Details

Completed

Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)

NCT05002907

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +23 more
Locations: General Hospital of Cayenne Cayenne, French Guiana

Foundation for Scientific Research Suriname (SWOS) Paramaribo, Suriname

View Trial Details

Completed

Dietary Fructose on Microbiota and Hepatosteatosis

NCT04898621

Conditions: Dietary Fructose Exposure, Digestive System Diseases, Fatty Liver, +3 more
Locations: Department of Endocrinology, Zhongshan Hospital Fudan University Shanghai, China

View Trial Details

Completed

The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes

NCT04509245

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +9 more
Locations: DDZ (Deutsches Diabetes Zentrum) Düsseldorf, North Rhine-Westphalia, Germany

View Trial Details

Completed

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

NCT01752920

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
Locations: Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States

Emory University, Winship Cancer Institute Atlanta, Georgia, United States

Karmanos Cancer Institute, Detroit Detroit, Michigan, United States

Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States

View Trial Details

Completed

Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes

NCT02637973

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +9 more
Locations: Charite Universitaetsmedizin Berlin Berlin, Germany

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Germany

German Diabetes Center Düsseldorf, Germany

University Clinic Heidelberg Heidelberg, Germany

View Trial Details

Completed

Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis.

NCT05883891

Conditions: Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +12 more
Locations: Agostino Gemelli Polyclinic Rome, Roma (provincia), Italy

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions